Background Increasing access to hepatitis C virus (HCV) care and treatment will require
simplified service delivery models. We aimed to evaluate the effects of decentralisation and …

Background The burden of hepatitis C virus (HCV) infection is escalating among people who
inject drugs (PWID), yet testing and treatment remains suboptimal. The aim of this systematic …

The burden of hepatitis C infection is considerable among people who inject drugs (PWID),
with an estimated prevalence of 39%, representing an estimated 6.1 million people who …

Globally, 12 million people are estimated to have injected drugs in the past year, 50% of
whom have chronic HCV infection, with people who have previously injected drugs …

In high income countries, the majority of new and existing hepatitis C virus (HCV) infections
occur among people who inject drugs (PWID). In many low and middle income countries …

Hepatitis C virus (HCV) is a global public health problem in correctional settings. The
International Network on Health and Hepatitis in Substance Users–Prisons Network is a …

Background Despite the key role that people who inject drugs (PWID) play in the hepatitis C
virus (HCV) epidemic, HCV treatment rates among this population have been historically …

Background People who inject drugs have high rates of hepatitis C (HCV) and yet many
remain undiagnosed and untreated. HCV treatment guidelines and elimination strategies …

Background Peer support can enable patient engagement with healthcare services,
particularly for marginalised populations. In this randomised controlled trial, the efficacy of a …

Abstract Background and Aims Previous studies have shown low rates of diagnosis and
treatment of hepatitis C virus (HCV) infection in people who inject drugs (PWID). Our aims …